| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Ajay Patel | EVP and CFO | 2026-02-21 | 566 | $11.84 | $6.70kSell |
| Sam Schlessinger | EVP General Counsel | 2026-02-21 | 510 | $11.84 | $6.04kSell |
| Paul Schwichtenberg | President and COO | 2026-02-21 | 566 | $11.84 | $6.70kSell |
| Paul Schwichtenberg | President and COO | 2026-02-18 | 1,377 | $11.87 | $16.34kSell |
| Ajay Patel | EVP and CFO | 2026-02-18 | 1,377 | $11.87 | $16.34kSell |
| Sam Schlessinger | EVP General Counsel | 2026-02-18 | 1,239 | $11.87 | $14.71kSell |
| Sam Schlessinger | EVP General Counsel | 2026-02-07 | 619 | $12.74 | $7.89kSell |
| Paul Schwichtenberg | President and COO | 2026-02-07 | 825 | $12.74 | $10.51kSell |
| Ajay Patel | EVP and CFO | 2026-02-07 | 825 | $12.74 | $10.51kSell |
| David Matthew Stark | Director | 2025-11-10 | 8,959 | $0.76 | $6.81kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Gavin Molinelli | 81.94% | 5,295,270 | $119.41M | Insider |
| Biovail Laboratories Inc | 65.64% | 4,242,032 | $95.66M | Insider |
| Kevin C. Tang | 59.08% | 3,817,600 | $86.09M | Insider |
| James A. Schoeneck | 13.82% | 892,840 | $20.13M | Insider |
| Arthur J. Higgins | 11.49% | 742,239 | $16.74M | Insider |
| Nantahala Capital Management LLC | 9.09% | 587,335 | $13.24M | Institution |
| Peter D. Staple | 7.79% | 503,295 | $11.35M | Insider |
| John N. Shell | 7.74% | 500,258 | $11.28M | Insider |
| Julian N. Stern | 5.29% | 341,666 | $7.70M | Insider |
| Daniel A. Peisert | 5.03% | 324,939 | $7.33M | Insider |